Opioid treatment drug ban buzz drags Dr Reddy's 6% in a firm market

The stock dipped 6% to Rs 2,536 on the BSE in intra-day trade on back of heavy volumes.

Dr Reddy’s Laboratories has dipped 6% to Rs 2,536 on the BSE in intra-day trade on back of heavy volumes on reports that the US appeals court rejected the drug firm’s request that would have allowed the company to sell a generic version of Indivior Plc’s Suboxone Film - a drug used for opioid addiction treatment - in the American market immediately.

The sales ban will remain in force to give Indivior time to challenge a November, 20 appeals court decision it lost. Indivior, according to reports, has until December, 20 to file a petition for rehearing in the